CTCXCarmell TherapeuticsCTCX info
$0.23info5.99%24h
Global rank5552
Market cap$5.31M
Change 7d-2.13%
YTD Performance-93.95%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Carmell Therapeutics (CTCX) Stock Overview

    Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

    CTCX Stock Information

    Symbol
    CTCX
    Address
    2403 Sidney StreetPittsburgh, PA 15203United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.carmellrx.com
    Country
    🇺🇸 United States
    Phone Number
    412 894 8248

    Carmell Therapeutics (CTCX) Price Chart

    -
    Value:-

    Carmell Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.23
    N/A
    Market Cap
    $5.31M
    N/A
    Shares Outstanding
    23.08M
    N/A
    Employees
    14.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org